1) Hit-lead optimization, design, and synthesis of new boron-based molecules for Glioblastoma and anti-tumor agents. 2) Design a synthetic pathway for novel chemical scaffolds and produce structural activity relationship (SAR) data around the Hits from high-throughput screening. 3) Design of small molecule to regulate mitochondrial function by inhibiting LonP1 protease for Glioblastoma and other fast malignancies, which heavily depend on hypoxic adaptation. 4) Evaluation of ADME properties, including compound solubility, protein binding, plasma stability, and metabolism.
University at Buffalo, State University of New York
Buffalo, Minnesota, USA
School of Pharmacy & Pharmaceutical Sciences